Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Postoperative Care
Interventions: Other: Early oral feeding; Other: Traditional Care
Sponsor: Hospital General de Agudos “Dr. Cosme Argerich”
Recruiting - verified March 2010
Condition: Colorectal Neoplasms
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing Remitting
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing Remitting
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin detemir (Levemir®); Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Conditions: Conditions Involved in Maternal Morbidity and Mortality; Conditions Contributing to Stillbirth and Neonatal Deaths
Interventions: Behavioral: Community Mobilization; Behavioral: Home-based Life Saving Skills; Behavioral: Facility improvement
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified December 2009
Condition: Intra-abdominal Infection
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039); Drug: Ertapenem, Amoxicillin/clavulanate
Sponsor: Bayer
Not yet recruiting - verified March 2010